319
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway
A ten-year national survey

Pages 520-529 | Received 29 Dec 2003, Accepted 10 May 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ingfrid S. Haldorsen, Ansgar Espeland, John Ludvig Larsen & Olav Mella. (2005) Diagnostic delay in primary central nervous system lymphoma. Acta Oncologica 44:7, pages 728-734.
Read now

Articles from other publishers (8)

I.S. Haldorsen, J. Kråkenes, B.K. Krossnes, O. Mella & A. Espeland. (2009) CT and MR Imaging Features of Primary Central Nervous System Lymphoma in Norway, 1989–2003. American Journal of Neuroradiology 30:4, pages 744-751.
Crossref
Ingfrid S. Haldorsen, Bård K. Krossnes, Jan H. Aarseth, David Scheie, Tom B. Johannesen, Olav Mella & Ansgar Espeland. (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003. Cancer 110:8, pages 1803-1814.
Crossref
Edo Richard, Matthijs C. Brouwer & Peter Portegies. 2007. HIV/AIDS and the Nervous System. HIV/AIDS and the Nervous System 221 228 .
Oussama Abla & Sheila Weitzman. (2006) Primary central nervous system lymphoma in children. Neurosurgical Focus 21:5, pages 1-8.
Crossref
April F. Eichler & Tracy T. Batchelor. (2006) Primary central nervous system lymphoma: presentation, diagnosis, and staging. Neurosurgical Focus 21:5, pages 1-9.
Crossref
Keishi Makino, Hideo Nakamura, Takeshi Kino, Hideo Takeshima & Jun-ichi Kuratsu. (2006) Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Surgical Neurology 66:5, pages 503-506.
Crossref
Scott R Plotkin. (2005) Update on primary central nervous system lymphoma. Current Opinion in Neurology 18:6, pages 645-653.
Crossref
April Fitzsimmons, Kristen Upchurch & Tracy Batchelor. (2005) Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma. Hematology/Oncology Clinics of North America 19:4, pages 689-703.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.